Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-16 4:21 pm Purchase |
2023-02-07 | 13G | Sintx Technologies, Inc. SINT |
Mitchell P. Kopin | 598 4.500% |
598 (New Position) |
Filing History |
| 2023-02-13 06:39 am Purchase |
2023-02-03 | 13G | Tenax Therapeutics, Inc. TENX |
Mitchell P. Kopin | 5,997 4.990% |
5,997 (New Position) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Pulmatrix, Inc. PULM |
Mitchell P. Kopin | 100,324 2.700% |
100,324 (New Position) |
Filing History |
| 2023-02-08 06:08 am Sale |
2022-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
Mitchell P. Kopin | 4,716 1.200% |
-1,919 (-28.92%) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Performance Shipping Inc. PSHG |
Mitchell P. Kopin | 266,666 6.200% |
266,666 (New Position) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 9.600% |
53,667 (New Position) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 6,686 7.600% |
6,686 (New Position) |
Filing History |
| 2023-02-08 06:07 am Unchanged |
2022-12-31 | 13G | Globus Maritime Limited GLBS |
Mitchell P. Kopin | 1,959,250 8.700% |
0 (Unchanged) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,204 5.600% |
82,687 (+1100.00%) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Histogen Inc. HSTO |
Mitchell P. Kopin | 240,375 5.300% |
240,375 (New Position) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 19,197 9.000% |
19,197 (New Position) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Hoth Therapeutics, Inc. HOTH |
Mitchell P. Kopin | 57,008 4.200% |
57,008 (New Position) |
Filing History |
| 2023-02-08 06:06 am Sale |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 54,600 6.300% |
-14,007 (-20.42%) |
Filing History |
| 2023-02-08 06:06 am Sale |
2022-12-31 | 13G | Helius Medical Technologies, Inc. HSDT |
Mitchell P. Kopin | 2,000 5.100% |
-1,333 (-40.00%) |
Filing History |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 916 9.400% |
916 (New Position) |
Filing History |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 27,092 5.100% |
27,092 (New Position) |
Filing History |
| 2023-02-08 06:06 am Unchanged |
2022-12-31 | 13G | Guardion Health Sciences, Inc. GHSI |
Mitchell P. Kopin | 5,000,000 7.500% |
0 (Unchanged) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Synaptogenix, Inc. SNPX |
Mitchell P. Kopin | 31,468 9.990% |
31,468 (New Position) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,918,959 9.990% |
687,477 (+55.83%) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL |
Mitchell P. Kopin | 540 9.990% |
227 (+72.64%) |
Filing History |